Boston Scientific Corp. (BSX)
46.84
+0.17
(+0.36%)
USD |
NYSE |
Aug 28, 16:00
46.84
0.00 (0.00%)
After-Hours: 20:00
Boston Scientific Enterprise Value : 79.98B for Aug. 28, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 79.98B |
| August 27, 2026 | 79.74B |
| August 26, 2026 | 81.91B |
| August 25, 2026 | 84.35B |
| August 24, 2026 | 83.12B |
| August 21, 2026 | 85.09B |
| August 20, 2026 | 83.64B |
| August 19, 2026 | 87.46B |
| August 18, 2026 | 85.23B |
| August 17, 2026 | 86.62B |
| August 14, 2026 | 87.20B |
| August 13, 2026 | 87.00B |
| August 12, 2026 | 86.61B |
| August 11, 2026 | 86.27B |
| August 10, 2026 | 85.22B |
| August 07, 2026 | 83.56B |
| August 06, 2026 | 83.54B |
| August 05, 2026 | 81.28B |
| August 04, 2026 | 83.24B |
| August 03, 2026 | 82.28B |
| July 31, 2026 | 79.82B |
| July 30, 2026 | 78.77B |
| July 29, 2026 | 78.82B |
| July 28, 2026 | 78.85B |
| July 27, 2026 | 78.06B |
| Date | Value |
|---|---|
| July 24, 2026 | 76.23B |
| July 23, 2026 | 75.27B |
| July 22, 2026 | 74.38B |
| July 21, 2026 | 74.70B |
| July 20, 2026 | 75.54B |
| July 17, 2026 | 75.92B |
| July 16, 2026 | 76.77B |
| July 15, 2026 | 74.48B |
| July 14, 2026 | 73.89B |
| July 13, 2026 | 76.81B |
| July 10, 2026 | 76.99B |
| July 09, 2026 | 77.31B |
| July 08, 2026 | 77.04B |
| July 07, 2026 | 77.75B |
| July 06, 2026 | 76.74B |
| July 02, 2026 | 77.52B |
| July 01, 2026 | 74.51B |
| June 30, 2026 | 73.96B |
| June 29, 2026 | 74.37B |
| June 26, 2026 | 75.48B |
| June 25, 2026 | 75.44B |
| June 24, 2026 | 75.83B |
| June 23, 2026 | 77.52B |
| June 22, 2026 | 75.63B |
| June 18, 2026 | 77.06B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 222.27B |
| Becton, Dickinson & Co. | 67.57B |
| Penumbra, Inc. | 12.22B |
| Intuitive Surgical, Inc. | 126.75B |
| Stryker Corp. | 138.81B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 905.00M |
| Revenue (Quarterly) | 5.442B |
| Total Expenses (Quarterly) | 4.535B |
| EPS Diluted (Quarterly) | 0.615 |
| Gross Profit Margin (Quarterly) | 66.50% |
| Profit Margin (Quarterly) | 16.63% |
| Earnings Yield | 5.26% |
| Operating Earnings Yield | 6.56% |
| Normalized Earnings Yield | 5.511 |